Aging Target
Agingtarget is a biotech startup dedicated to developing treatments for age-related diseases and functional ingredients to meet the healthcare needs of an aging society. The company focuses on anti-aging therapeutics for cardiovascular and neurological diseases, including Alzheimer's and cancer, aiming to extend healthspan and address the risks associated with population aging.
Industries
Nr. of Employees
small (1-50)
Aging Target
Gyeonggi-do Gwacheon-si Gwacheon-daero 7na-gil 60, Gwacheon Urban Hub A Building 2nd Floor 202
Products
Cardiovascular aging inhibition therapeutic candidates
Preclinical-stage therapeutic candidates intended to inhibit senescence in cardiac and vascular cells to address age-related cardiovascular conditions.
Atherosclerosis therapy candidates based on vascular-aging inhibition
Therapeutic candidates for atherosclerosis that act via modulation of vascular aging processes rather than primarily lowering LDL-C.
Multi-target Alzheimer's therapeutic candidates
Preclinical candidates designed to act on multiple Alzheimer’s disease pathogenic mechanisms concurrently.
Alzheimer's therapeutics based on glial-cell senescence inhibition
Candidate therapeutics aimed at preventing neuronal damage by suppressing senescence in non-neuronal brain cells (glia).
Radiation therapy efficacy enhancers (preclinical candidates)
Agents intended to increase tumor responsiveness to ionizing radiation by promoting cancer cell growth inhibition, apoptosis, or senescence.
Brain and cardiovascular health functional-ingredient products
Isolated bioactive plant-derived ingredients formulated for use in health functional foods targeting brain and cardiovascular function.
Cardiovascular aging inhibition therapeutic candidates
Preclinical-stage therapeutic candidates intended to inhibit senescence in cardiac and vascular cells to address age-related cardiovascular conditions.
Atherosclerosis therapy candidates based on vascular-aging inhibition
Therapeutic candidates for atherosclerosis that act via modulation of vascular aging processes rather than primarily lowering LDL-C.
Multi-target Alzheimer's therapeutic candidates
Preclinical candidates designed to act on multiple Alzheimer’s disease pathogenic mechanisms concurrently.
Alzheimer's therapeutics based on glial-cell senescence inhibition
Candidate therapeutics aimed at preventing neuronal damage by suppressing senescence in non-neuronal brain cells (glia).
Radiation therapy efficacy enhancers (preclinical candidates)
Agents intended to increase tumor responsiveness to ionizing radiation by promoting cancer cell growth inhibition, apoptosis, or senescence.
Brain and cardiovascular health functional-ingredient products
Isolated bioactive plant-derived ingredients formulated for use in health functional foods targeting brain and cardiovascular function.
Services
In vitro and in vivo preclinical screening and identification of candidate therapeutic molecules targeting cellular senescence and age-related disease mechanisms.
Extraction and formulation of bioactive components from medicinal plants to produce ingredients for brain- and cardiovascular-function improvement foods aimed at individual-recognition submission.
In vitro and in vivo preclinical screening and identification of candidate therapeutic molecules targeting cellular senescence and age-related disease mechanisms.
Extraction and formulation of bioactive components from medicinal plants to produce ingredients for brain- and cardiovascular-function improvement foods aimed at individual-recognition submission.
Expertise Areas
- Preclinical drug discovery for age-related diseases
- Cardiovascular aging therapeutics
- Alzheimer's disease therapeutics
- Radiation therapy sensitizer development
Key Technologies
- Cell culture
- Diet-induced and angiotensin II–induced in vivo vascular aging models
- Natural product extraction and isolation
- Senescence-targeting drug discovery